US Patent 9388246 TLR3 binding agents
Patent 9388246 was granted and assigned to Innate Pharma on July, 2016 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9388246 TLR3 binding agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
